Cargando…
Therapeutic Strategies for COVID-19 Lung Disease in Children
The novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has milder presentation in children than in adults, mostly requiring only supportive therapy. The immunopathogenic course of COVID-19 can be divided in two distinct but overlapping phases: the first triggered by the vir...
Autores principales: | Gatti, Elisabetta, Piotto, Marta, Lelii, Mara, Pensabene, Mariacarola, Madini, Barbara, Cerrato, Lucia, Hassan, Vittoria, Aliberti, Stefano, Bosis, Samantha, Marchisio, Paola, Patria, Maria Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936419/ https://www.ncbi.nlm.nih.gov/pubmed/35321012 http://dx.doi.org/10.3389/fped.2022.829521 |
Ejemplares similares
-
Can Asymptomatic or Non-Severe SARS-CoV-2 Infection Cause Medium-Term Pulmonary Sequelae in Children?
por: Bottino, Ilaria, et al.
Publicado: (2021) -
Pediatric Sleep Respiratory Disorders: A Narrative Review of Epidemiology and Risk Factors
por: Piotto, Marta, et al.
Publicado: (2023) -
Cytokines Profile and Lung Function in Children with Obesity and Asthma: A Case Control Study
por: Maffeis, Laura, et al.
Publicado: (2022) -
Kikuchi-Fujimoto disease in children: two case reports and a review of the literature
por: Lelii, Mara, et al.
Publicado: (2018) -
Caregivers' Attitudes Toward COVID-19 Vaccination in Children and Adolescents With a History of SARS-CoV-2 Infection
por: Buonsenso, Danilo, et al.
Publicado: (2022)